Locoreginal radioimmunotherapy with 186Re-labeled monoclonal antibody in treating small peritoneal carcinomatosis of colon cancer in mice in comparison with 131I-counterpart

Cancer Letters

Volumn 219, Issue 1, 2005, Pages 41-48

  Kinuya, Seigo ^a   Yokoyama, Kunihiko ^a   Izumo, Mishiroku ^b   Sorita, Takami ^b   Obata, Takashi ^b   Mori, Hirofumi ^a   Shiba, Kazuhiro ^a   Watanabe, Naoto ^c   Shuke, Noriyuki ^d   Michigishi, Takatoshi ^a   Tonami, Norihisa ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b JAPAN ATOMIC ENERGY AGENCY   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

186Re; Colon cancer; Locoregional administration; Peritoneal metastasis; Radioimmunotherapy

Indexed keywords

FLUOROURACIL; IODINE 131; MONOCLONAL ANTIBODY; RHENIUM 186; RADIOACTIVE IODINE; RADIOISOTOPE; RHENIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOMATOSIS; COLON CANCER; CONTROLLED STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; TUMOR REGRESSION; TUMOR VOLUME; ANIMAL; COLON TUMOR; COMPARATIVE STUDY; DISEASE MODEL; INTRAPERITONEAL DRUG ADMINISTRATION; MAXIMUM TOLERATED DOSE; METASTASIS; METHODOLOGY; PERITONEUM TUMOR; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODIES, MONOCLONAL; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAPERITONEAL; IODINE RADIOISOTOPES; MAXIMUM TOLERATED DOSE; MICE; PERITONEAL NEOPLASMS; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RHENIUM; TISSUE DISTRIBUTION;

EID: 20144363814     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.08.033     Document Type: Article

References (34)

1. A. Yamaguchi, Y. Tsukioka, S. Fushida, Y. Kurosaka, M. Kanno, and Y. Yonemura Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancers Dis. Colon Rectum 35 1992 964 968
2. M. Markmam Intraperitoneal chemotherapy in the management of colon cancer Semin. Oncol. 26 1999 536 539
3. S.R. Pestieau, and P.H. Sugarbaker Treatment of primary colon cancer with peritoneal carcinomatosis Dis. Colon Rectum 43 2000 1341 1348
4. R.M. Sharkey, K.S. Weadock, A. Natale, L. Haywood, R. Aninipot, R.D. Blumenthal, and D.M. Goldenberg Successful radioimmunotherapy for lung metastasis of human colonic cancer in nude mice J. Natl Cancer Inst. 83 1991 627 632
5. J.S. Stewart, V. Hird, D. Snook, B. Dhokia, G. Sivolapenko, and G. Hooker Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer J. Clin. Oncol. 8 1990 1941 1950
6. A. Maraveyas, D. Snook, V. Hird, C. Kosmas, C.F. Meares, H.E. Lambert, and A.A. Epenetos Pharmacokinetics and toxicity of an yttrium-90-CITC-DTPA-HMFG1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer Cancer 73 1994 1067 1075
7. R.F. Meredith, E.E. Partridge, R.D. Alvarez, M.B. Khazaeli, G. Plott, and C.D. Russell Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49 J. Nucl. Med. 37 1996 1491 1496
8. P.E. Borchardt, S.M. Quadri, R.S. Freedman, and H.M. Vriesendorp Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice J. Nucl. Med. 39 1998 476 484
9. W.C. Buijs, J.G. Tibben, O.C. Boerman, C.F. Molthoff, L.F. Massuger, and E.B. Koenders Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration Eur. J. Nucl. Med. 25 1998 1552 1561
10. M.A. Mahe, P. Fumoleau, M. Fabbro, J.P. Guastalla, P. Faurous, and P. Chauvot A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma Clin. Cancer Res. 5 1999 3249s 3253s
11. 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity Clin. Cancer Res. 5 1999 953 961
12. P.E. Borchardt, S.M. Quadri, R.S. Freedman, and H.M. Vriesendorp Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis Cancer Biother. Radiopharm. 15 2000 53 64
13. R.F. Meredith, R.D. Alvarez, E.E. Partridge, M.B. Khazaeli, C.Y. Lin, and D.J. Macey Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I study Cancer Biother. Radiopharm. 16 2001 305 315
14. G. Rowlinson, D. Snook, A. Busza, and A.A. Epenetos Antibody-guided localization of intraperitoneal tumors following intraperitoneal or intravenous antibody administration Cancer Res. 47 1987 6528 6531
15. S.M. Larson, J.A. Carrasquillo, D.C. Colcher, K. Yokoyama, J.C. Reynolds, and S.A. Bacharach Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatoses J. Nucl. Med. 32 1991 1661 1667
16. S.M. Quadri, A.B. Malik, X.Z. Tang, R. Patenia, R.S. Freedman, and H.M. Vriesendorp Preclinical analysis of intraperitoneal administration of 111In-labeled human tumor reactive monoclonal IgM AC6C3-2B12 Cancer Res. 55 1995 5736s 5742s
17. S.M. Quadri, A.B. Malik, H.B. Chu, R.S. Freedman, and H.M. Vriesendorp Intraperitoneal indium-111- and yttrium-90-labeled human IgM (AC6C3-2B12) in nude mice bearing peritoneal carcinomatosis J. Nucl. Med. 37 1996 1545 1551
18. 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts Clin. Cancer Res. 5 1999 2994s 3000s
19. S.K. Imam Status of radioimmunotherapy in the new millennium Cancer Biother. Radiopharm. 16 2001 237 256
20. S. Kinuya, X.-F. Li, K. Yokoyama, H. Mori, K. Shiba, and N. Watanabe Intraperitoneal radioimmunotherapy in treating peritoneal carcinomatosis of colon cancer in mice compared with systemic radioimmunotherapy Cancer Sci. 94 2003 650 654
21. H. Kotanagi, T. Takahashi, T. Masuko, Y. Hashimoto, and K. Koyama A monoclonal antibody against human colon cancers Tohoku J. Exp. Med. 148 1986 353 360
22. 131I- counterpart Ann. Nucl. Med. 15 2001 199 202
23. S. Kinuya, A. Kawashima, K. Yokoyama, K. Koshida, S. Konishi, and N. Watanabe Cooperative effect of radioimmunotherapy and antiangiogenic therapy with thalidomide in human cancer xenografts J. Nucl. Med. 43 2002 1084 1089
24. 186Re-labeled monoclonal antibody to treat liver metastases of colon cancer cells in nude mice Cancer Biother. Radiopharm. 17 2002 681 687
25. 186Re-radioimmunotherapy for treatment in an adjuvant setting of colon cancer J. Cancer Res. Clin. Oncol. 129 2003 392 396
26. S. Kinuya, K. Yokoyama, H. Tega, T. Hiramatsu, S. Konishi, and W. Yamamoto Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice Jpn J. Cancer Res. 89 1998 870 878
27. K. Fujimori, and M. Furudate Dosimetry and radiation dose distribution in tumors for radioimmunotherapy: the effect of tumor size Jpn J. Nucl. Med. (KAKUIGAKU) 31 1994 241 248
28. S. Kinuya, K. Yokoyama, H. Tega, T. Hiramatsu, S. Konishi, and N. Watanabe Efficacy, toxicity and mode of interaction of combination radioimmunotherapy with 5-fluorouracil in colon cancer xenografts J. Cancer Res. Clin. Oncol. 125 1999 630 636
29. J.A. O'Donoghue, M. Bardies, and T.E. Wheldon Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides J. Nucl. Med. 36 1995 1902 1909
30. M.E. Juweid Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice J. Nucl. Med. 43 2002 1507 1529
31. D.J. Macey, and R.F. Meredith A strategy to reduce red marrow dose for intraperitoneal radioimmunotherapy Clin. Cancer Res. 5 Suppl. 1999 3044s 3047s
32. 186Re- labeled monoclonal antibody: methods and results Cancer Res. 55 Suppl. 1995 5817 5822
33. H.B. Brietz, D.R. Fisher, P.L. Weiden, J.S. Durham, B.A. Ratliff, and M.J. Bjorn Dosimetry of rhenium-186-labeled monoclonal antibodies: methods, prediction from technetium-99m-labeled antibodies and results of phase 1 trials J. Nucl. Med. 34 1993 908 917
34. K. Yoshida, T. Fujikawa, G. Yoshizawa, A. Tanabe, and K. Sakurai Biodistribution of radiolabeled monoclonal antibody after intraperitoneal administration in nude mice with hepatic metastasis from human colon cancer Surg. Today 22 1992 155 158